0001610717-24-000229.txt : 20240503
0001610717-24-000229.hdr.sgml : 20240503
20240503193638
ACCESSION NUMBER: 0001610717-24-000229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anders Jack
CENTRAL INDEX KEY: 0001800668
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 24915114
MAIL ADDRESS:
STREET 1: C/O REVOLUTION MEDICINES, INC.
STREET 2: 700 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-05-03
0001628171
Revolution Medicines, Inc.
RVMD
0001800668
Anders Jack
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
Chief Financial Officer
true
Common Stock
2024-05-03
4
M
0
10000
2.68
A
111959
D
Common Stock
2024-05-03
4
S
0
10000
40.026
D
101959
D
Stock Option (Right to Buy)
2.68
2024-05-03
4
M
0
10000
0
D
2022-08-16
2028-09-26
Common Stock
10000
12814
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023.
Includes 60,250 restricted stock units.
This transaction was executed in multiple trades in prices ranging from $40.00 to $40.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Jack Anders
2024-05-03